US HJR145 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on May 16 2024 - 25% progression
Action: 2024-05-16 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 16 2024 - 25% progression
Action: 2024-05-16 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".
Title
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".
Sponsors
Rep. Brad Finstad [R-MN] | Rep. Dan Crenshaw [R-TX] | Rep. Pete Sessions [R-TX] |
History
Date | Chamber | Action |
---|---|---|
2024-05-16 | House | Referred to the House Committee on Energy and Commerce. |
2024-05-16 | House | Introduced in House |
Same As/Similar To
SJR82 (Same As) 2024-05-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-joint-resolution/145/all-info |
Text | https://www.congress.gov/118/bills/hjres145/BILLS-118hjres145ih.pdf |